| Glioblastoma Stem Cells as a New Therapeutic Target for Glioblastoma R Kalkan Clinical Medicine Insights: Oncology 2 9, 95-103, 2015 | 63 | 2015 |
| Importance of m N6-methyladenosine (m6A) RNA modification in cancer RK Gulten Tuncel Medical Oncology 36 (36), 2019 | 59 | 2019 |
| The chondrocyte cell proliferation of a chitosan/silk fibroin/egg shell membrane hydrogels LK Terin Adali, Rasime Kalkan International Journal of Biological Macromolecules 124, 2019 | 42 | 2019 |
| IDH1 mutations is prognostic marker for primary glioblastoma multiforme but MGMT hypermethylation is not prognostic for primary glioblastoma multiforme R Kalkan, Eİ Atli, M Özdemir, E Çiftçi, HE Aydin, S Artan, A Arslantaş Gene 554 (1), 81-86, 2015 | 34 | 2015 |
| The use of scaffolds in cartilage regeneration R Kalkan, CW Nwekwo, T Adali Critical Reviews™ in Eukaryotic Gene Expression 28 (4), 2018 | 31 | 2018 |
| RANK/RANKL/OPG pathway is an important for the epigenetic regulation of obesity. EB Rasime Kalkan Mol Biol Rep., 2019 | 26 | 2019 |
| Receptor tyrosine kinase-Ras-PI 3 kinase-Akt signaling network in glioblastoma multiforme G Tuncel, R Kalkan Medical Oncology 35, 1-12, 2018 | 26 | 2018 |
| Hypoxia Is the Driving Force Behind GBM and Could Be a New Tool in GBM Treatment R Kalkan Critical Reviews™ in Eukaryotic Gene Expression 25 (4), 363-369, 2015 | 20 | 2015 |
| The Impacts of miRNAs in Glioblastoma Progression R Kalkan, Eİ Atli Critical Reviews™ in Eukaryotic Gene Expression 26 (2), 2016 | 18 | 2016 |
| The interactions between bone remodelling, estrogen hormone and EPH family genes R Kalkan, P Tulay Critical Reviews™ in Eukaryotic Gene Expression 28 (2), 2018 | 17 | 2018 |
| Genetic and Epigenetic Alterations in Autism Spectrum Disorder RK Bugsem Oztenekecioglu, Merdiye Mavis, Meryem Osum Global Med Genet, 2021 | 12* | 2021 |
| Role of Mesenchymal Stem Cells in Cancer Development and Their Use in Cancer Therapy N Serakinci, P Tulay, R Kalkan Springer, Boston, MA, 2018 | 12 | 2018 |
| A New Perspective of COVID-19 Infection: An Epigenetics Point of View RK Ziya Ozturkler Global Med Genet 8, 2021 | 10* | 2021 |
| The Importance of Mutational Drivers in GBM R Kalkan Critical Reviews™ in Eukaryotic Gene Expression 26 (1), 19-26, 2016 | 10 | 2016 |
| Genetic and epigenetic perspective of microbiota RK Cigdem Celiker Applied Microbiology and Biotechnology 104 (18), 10.1007/s00253-020-10849-9, 2020 | 9* | 2020 |
| Epigenetics of glioblastoma multiforme K Rasime Journal of Clinical Research & Bioethics 6 (3), 1, 2015 | 9 | 2015 |
| A unique mosaic Turner syndrome patient with androgen receptor gene derived marker chromosome NS Rasime Kalkan, Nermin Özdağ, Rüveyde Bundak, Ayşe Çirakoğlu Systems Biology in Reproductive Medicine 1, 2016 | 8* | 2016 |
| Epigenetic Alteration in Colorectal Cancer: A Biomarker for Diagnostic and Therapeutic Application RK Hafsa Yousif Solayman Essa, Gunay Kusaf, Ozel Yuruker Global Medical Genetics 9, 258–262, 2022 | 7 | 2022 |
| Cancer treatment: an epigenetic view C Aydin, R Kalkan Global medical genetics 7 (01), 003-007, 2020 | 7 | 2020 |
| The Use of Molecular Cytogenetic Techniques for the Identification of Chromosomal Abnormalities R Kalkan Chromosomal Abnormalities-A Hallmark Manifestation of Genomic Instability, 2017 | 7 | 2017 |
emine ikbal atlitrakya üniversitesitrakya.edu.tr üzerinde doğrulanmış e-posta adresine sahip
